Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7.23M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
23.2M
-
Shares change
-
+4.71M
-
Total reported value, excl. options
-
$120M
-
Value change
-
+$25.8M
-
Put/Call ratio
-
0.68
-
Number of buys
-
56
-
Number of sells
-
-25
-
Price
-
$5.18
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q2 2020
93 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q2 2020.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.2M shares
.
Largest 10 shareholders include Bellevue Group AG (4.24M shares), BlackRock Inc. (2.06M shares), FRANKLIN RESOURCES INC (2.03M shares), FMR LLC (1.94M shares), VANGUARD GROUP INC (1.55M shares), Cormorant Asset Management, LP (1.3M shares), MILLENNIUM MANAGEMENT LLC (859K shares), BAKER BROS. ADVISORS LP (600K shares), Candriam Luxembourg S.C.A. (600K shares), and Alyeska Investment Group, L.P. (589K shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.